The market for psychedelic drugs to treat mental health conditions gets a big buy signal

Business Archived • July 19, 2026 • 12 views

Eli Lilly's acquisition of psychedelic drug maker AtaiBeckley extends Big Pharma's embrace of a stigmatized class of medications for treating mental health.

Source: https://search.cnbc.com/rs/search/combinedcms/view.xml?partnerId=wrss01&id=100003114 - Read Original